Bibliometric analysis of stereotactic ablative radiotherapy for oligometastases
Abstract
Background: Oligometastases, an intermediate stage of metastatic cancer, are increasingly managed with Stereotactic Ablative Radiotherapy (SABR), a highly precise local therapy representing a pivotal paradigm shift for improving patient outcomes. This study aimed to comprehensively map the research landscape of SABR for oligometastases.
Methods: We conducted a cross-sectional bibliometric analysis of 1,066 publications from the Web of Science Core Collection and PubMed from January 1, 2006, to December 31, 2025. Publication trends, key contributors, and collaboration networks were quantified and visualized using bibliometrix, VOSviewer, and CiteSpace.
Results: Our results indicate significant and consistent growth in this field since 2006, with the United States, Italy, and Canada as leading countries, and Humanitas University among the most productive institutions, alongside key authors like Marta Scorsetti. Influential research appeared in leading oncology journals, and keyword analysis identified hotspots in cancer types, metastatic sites, treatment strategies, and the integration of immunotherapy and AI. Landmark clinical trials (e.g., SABR-COMET, ORIOLE) were highly cited.
Conclusion: This comprehensive overview underscores the rapid development, international collaboration, and critical research directions within the field, highlighting SABR's translational potential and providing a foundation for identifying future research priorities.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.